PROphetNSCLC Test

**Semantic type:** Laboratory Procedure

**Definition:** An assay that predicts whether a non-small cell lung cancer (NSCLC) patient may experience a clinical benefit, defined as progression-free survival greater than 12 months, following PD-1/PD-L1 inhibitor immunotherapy-based treatment plans. It uses a plasma-based proteomic pattern recognition tool to identify expression patterns in a panel of approximately 7,000 proteins and assign a score that reflects the patient's likelihood of clinical benefit.

**Synonyms:** - Oncohost PROphet NSCLC Assay - PROphet NSCLC Assay - PROphet NSCLC Test - PROphet Non-small Cell Lung Cancer Assay